Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures.

Jeong, Y; Jin, B; Lee, H W; Park, H J; Park, J Y; Kim, D Y; Han, K-H; Ahn, S H; Kim, S

Jeong, Y; Jin, B; Lee, H W; Park, H J; Park, J Y; Kim, D Y; Han, K-H; Ahn, S H; Kim, S.

Affiliation

Jeong Y; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Jin B; Yonsei Liver Center, Severance Hospital, Seoul, Korea.
Lee HW; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Park HJ; Yonsei Liver Center, Severance Hospital, Seoul, Korea.
Park JY; Yonsei Liver Center, Severance Hospital, Seoul, Korea.
Kim DY; Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Han KH; Yonsei Liver Center, Severance Hospital, Seoul, Korea.
Ahn SH; Yonsei Liver Center, Severance Hospital, Seoul, Korea.
Kim S; Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

J Viral Hepat ; 25(11): 1251-1259, 2018 11.

Article in En | MEDLINE | ID: mdl-29768695

Subject(s)
Key words

asunaprevir; daclatasvir; hepatitis C virus; resistance-associated substitution; viral fitness

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepacivirus / Hepatitis C, Chronic / Drug Resistance, Viral Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2018 Document type: Article Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google